A significant breakthrough in cancer investigation is emerging with the use of nanobodies to reactivate damaged p53. This essential tumor inhibitor protein is frequently lost in several kinds of tumors, resulting https://zanybookmarks.com/story22066864/mini-antibodies-reactivate-the-p53-protein-new-new-approach-for-malignant-management